Lung Cancer with Brain Metastases Treated with Radiotherapy Followed by Bevacizumab Maintenance: A Case Report

Brain metastases in a patient with non-small cell lung cancer carry a grave prognosis. Without effective interventions, the average survival rate is 6 months. Here, we present a case of a 59-year-old male with non-small cell lung cancer and multiple brain metastases treated with radiotherapy followe...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Sajjad Ahmed, Gautam, Sakshyam, Sapkota, Sulav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of the Nepal Medical Association 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275467/
https://www.ncbi.nlm.nih.gov/pubmed/35690983
http://dx.doi.org/10.31729/jnma.7400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275467/
https://www.ncbi.nlm.nih.gov/pubmed/35690983
http://dx.doi.org/10.31729/jnma.7400

Ejemplares similares